Seed VC · New York / London / Madrid
Accelerating breakthroughs in longevity, health, AI, and carbon/climate. Science is extending life; AI is accelerating science adoption. Goal of 150 years life expectancy this century and 150 ppm carbon dioxide removal by 2050.
Business models
saas_b2b, deeptech_ip, platform, services, biotech_therapeutics
Customer segments
Enterprise, Researchers, Biopharma, Employers, SMB, Consumers
Geography
US, Europe, UK, APAC
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
LifeX Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. Claude Fundraiser tracks LifeX Ventures alongside 45,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. Claude scores it on the 8 dimensions VCs read for and ranks the 45,000+ active investors in the database by fit. LifeX Ventures is one of them — and we'll tell you exactly where they sit in your top 100.